Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Identify the key factors to evaluate retirement index funds in 2024, including fees, diversification, and historical performance context.
21,429 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
ai healthcare news is accelerating how we diagnose, treat, and manage care. This guide breaks down the trends, how to...
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
As Toro prepares to report and discuss its 2026 earnings, investors want clarity on demand, margins, and guidance. Th...
Nvidia is delivering a hopeful signal for investors as its expanding enterprise AI software platform intrigues buyers...
A dramatic 72% decline in a key internet infrastructure stock drew a bold $12 million investment. This article explai...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Powell Industries may fly under the radar, but patient investors can uncover a potential opportunity. This guide brea...
Amazon isn’t only about Prime or AWS. An underrated reason to invest Amazon stock is its fast-growing advertising bus...